| Multiple sclerosis—the plaque and its pathogenesis EM Frohman, MK Racke, CS Raine New England Journal of Medicine 354 (9), 942-955, 2006 | 2288 | 2006 |
| Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. MK Racke, A Bonomo, DE Scott, B Cannella, A Levine, CS Raine, ... The Journal of experimental medicine 180 (5), 1961-1966, 1994 | 772 | 1994 |
| Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement MS Freedman, EJ Thompson, F Deisenhammer, G Giovannoni, ... Archives of neurology 62 (6), 865-870, 2005 | 740 | 2005 |
| T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis JM Critchfield, MK Racke, JC Zúñiga-Pflücker, B Cannella, CS Raine, ... Science 263 (5150), 1139-1143, 1994 | 629 | 1994 |
| Immune surveillance in multiple sclerosis patients treated with natalizumab O Stüve, CM Marra, KR Jerome, L Cook, PD Cravens, S Cepok, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 495 | 2006 |
| Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. MK Racke, S Dhib-Jalbut, B Cannella, PS Albert, CS Raine, DE McFarlin Journal of immunology (Baltimore, Md.: 1950) 146 (9), 3012-3017, 1991 | 452 | 1991 |
| Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells K Ghoreschi, J Brück, C Kellerer, C Deng, H Peng, O Rothfuss, ... Journal of Experimental Medicine 208 (11), 2291-2303, 2011 | 414 | 2011 |
| Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ12, 1412, 14-prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis A Diab, C Deng, JD Smith, RZ Hussain, B Phanavanh, AE Lovett-Racke, ... The Journal of Immunology 168 (5), 2508-2515, 2002 | 372 | 2002 |
| T-bet is essential for encephalitogenicity of both Th1 and Th17 cells Y Yang, J Weiner, Y Liu, AJ Smith, DJ Huss, R Winger, H Peng, ... Journal of Experimental Medicine 206 (7), 1549-1564, 2009 | 350 | 2009 |
| High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay MP Crawford, SX Yan, SB Ortega, RS Mehta, RE Hewitt, DA Price, ... blood 103 (11), 4222-4231, 2004 | 344 | 2004 |
| T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity AR Gocke, PD Cravens, LH Ben, RZ Hussain, SC Northrop, MK Racke, ... The Journal of Immunology 178 (3), 1341-1348, 2007 | 342 | 2007 |
| Factors that influence adherence with disease-modifying therapy in MS K Treadaway, G Cutter, A Salter, S Lynch, J Simsarian, J Corboy, ... Journal of neurology 256, 568-576, 2009 | 338 | 2009 |
| Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. AE Lovett-Racke, JL Trotter, J Lauber, PJ Perrin, CH June, MK Racke The Journal of clinical investigation 101 (4), 725-730, 1998 | 334 | 1998 |
| Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. MK Racke, D Burnett, SH Pak, PS Albert, B Cannella, CS Raine, ... Journal of immunology (Baltimore, Md.: 1950) 154 (1), 450-458, 1995 | 331 | 1995 |
| CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. PJ Perrin, JH Maldonado, TA Davis, CH June, MK Racke Journal of immunology (Baltimore, Md.: 1950) 157 (4), 1333-1336, 1996 | 319 | 1996 |
| IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease M Röcken, M Racke, EM Shevach Immunology today 17 (5), 225-231, 1996 | 319 | 1996 |
| Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis O Stüve, CM Marra, A Bar-Or, M Niino, PD Cravens, S Cepok, ... Archives of neurology 63 (10), 1383-1387, 2006 | 308 | 2006 |
| Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis R Zivadinov, AT Reder, M Filippi, A Minagar, O Stuve, H Lassmann, ... Neurology 71 (2), 136-144, 2008 | 300 | 2008 |
| The utility of MRI in suspected MS [RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology EM Frohman, DS Goodin, PA Calabresi, JR Corboy, PK Coyle, M Filippi, ... Neurology 61 (5), 602-611, 2003 | 285 | 2003 |
| Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant isocitrate dehydrogenase 2: analysis of a phase 1/2 study AT Fathi, CD DiNardo, I Kline, L Kenvin, I Gupta, EC Attar, EM Stein, ... JAMA oncology 4 (8), 1106-1110, 2018 | 282* | 2018 |
